Access Campaign News

Access Campaign News

MSF protests at Johnson & Johnson’s annual shareholders' meeting to demand a say in how lifesaving tuberculosis drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable. New Brunswick, New Jersey - At the…
MSF: Johnson & Johnson should make TB drug available for all at $1/day
On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have taken to try to protect access…
MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline.…
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Geneva —The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed new World Health Organization (WHO) treatment guidelines that recommend drug-resistant tuberculosis (DR-TB) be treated with oral drugs only, including newer, more…
Geneva - On the eve of the Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on the Board to make urgent changes to Global Fund policies and practices for…
Access to medicines: HIV and TB treatment at risk as countries gradually lose Global Fund support
The Hague — Activists interrupted the opening ceremony of the 49th Union World Conference on Lung Health in The Hague today, to call on US pharmaceutical corporation Johnson & Johnson (J&J) to cut the price of the TB drug bedaquiline in half, to ‘one dollar per day’, so that people who…
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day
The Hague — People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment in part because of high drug prices, according to a new report — DR-TB Drugs Under the Microscope — released today by Doctors Without Borders/Médecins Sans Frontières (MSF) at the…
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
Sharonann Lynch, HIV & TB advisor for Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement today following the first-ever United Nations High-Level Meeting on Tuberculosis (TB): “The good news is this historic meeting happened at a time when the…
MSF response to first-ever UN tuberculosis summit
New York — As global leaders gather for the first-ever United Nations tuberculosis (TB) Summit in New York this week, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) called on governments to save more lives by scaling up TB testing and…
Global leaders must make bold commitments at first-ever UN tuberculosis summit
Gilead’s price gouging for Sofosbuvir blocks millions of people from getting treatment Munich/Paris/New York – This week in Munich, the European Patent Office is hearing a legal challenge filed by groups in 17 countries in March 2017 against an unmerited patent that allows US pharmaceutical…
MSF and groups call for end to Gilead’s unwarranted hepatitis C grug monopoly in Europe